Tender Details

Country: Estonia
Summary: Antineoplastic and Immunosuppressive Drugs
EET Ref No: 123725945
Deadline: 02 Sep 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 506255-2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The purpose of this procurement is to enter into a framework contract for the purchase of antineoplastic and immunosuppressive drugs on the basis of the names and descriptions set out in Annex 1, HD. / Fundamentals and Conditions of Elimination: View Procurement Basic Documents
L01aa01 Cyclophosphamide
1G / inj Subst / Elimination Basics and Conditions: View Procurement Basic Documents
L01aa03 Melphalan
50mg / Inj Subst / Removal Basics and Qualifying Terms: See Procurement Basic Documents
L01aa06 ifosfam
L01AX03 temozolomid
100mg / hard capsule / basics and qualification conditions: see from the source documents of the procurement
140mg / hard capsule / bases for elimination and qualification conditions: See the source documents of the procurement
L01ab01 Busulfan
6mg/ Inf Conc / Removal Basics and Qualifying Terms: See the Procurement Basic Documents
Conc. / Bases for elimination and Qualifying Terms: View Procurement Basic Documents
Conc. / Fundamentals and Conditions of Elimination: View Procurement Basic Documents
L01b01 methodrexat
100mg/ ml-50ml/ inf. 50mg/ 2ml/ inf. Conc. / Fundamentals and Conditions of Elimination: View Procurement Basic Documents
L01bb04 kladribin
10mg/ 5ml/ Inj/ Elementary Survey Basics and Qualifying Terms: See the Procurement Basic Documents
L01bb05 Fludarabine
50 mg/ inf. / Fundamentals of elimination and qualification conditions: Promise...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Antineoplastic and Immunosuppressive Drugs - Estonia Tender

The FOUNDATION TARTU UNIVERSITY CLINIC, a Government sector organization in Estonia, has announced a new tender for Antineoplastic and Immunosuppressive Drugs. This tender is published on EstoniaTenders under EET Ref No: 123725945 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-02.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.